In contrast, doxorubicin-induced apoptosis was significantly increased in LAPTM4B knockdown breast cancer cells, suggesting that LAPTM4B might play a role in inhibiting cell survival in breast cancer (75). This evidence concerns the gene LAPTM4B and breast carcinoma.